FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Peter Büchler

Research Profile

Disorders

Anatomy

Living Beings

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Survival Rate

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Norbert Hüser; Arno Kornberg; Alexander R Novotny; Daniel Reim; Stefan Thorban; Volker Assfalg; Peter Büchler; Zhangjun Cheng; Helmut Friess; Edouard Matevossian
Heparin-induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors.
Yun Su; Markus W Büchler; Helmut Friess; Natalia Giese; Arno Kornberg; Martin Loos; Eric Metzen; Peter Büchler
Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
Nader Joghetaei; Gregor Weirich; Peter Büchler; Wolfgang Huber; Heidi Estner
Acute liver failure associated with dronedarone.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Peter Büchler (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2012: Norbert Hüser; Arno Kornberg; Alexander R Novotny; Daniel Reim; Stefan Thorban; Volker Assfalg; Peter Büchler; Zhangjun Cheng; Helmut Friess; Edouard Matevossian
Heparin-induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors.
Transplant international : official journal of the European Society for Organ Transplantation 2012;25(7):739-47.
2012: Yun Su; Markus W Büchler; Helmut Friess; Natalia Giese; Arno Kornberg; Martin Loos; Eric Metzen; Peter Büchler
Prolyl hydroxylase-2 (PHD2) exerts tumor-suppressive activity in pancreatic cancer.
Cancer 2012;118(4):960-72.
2011: Nader Joghetaei; Gregor Weirich; Peter Büchler; Wolfgang Huber; Heidi Estner
Acute liver failure associated with dronedarone.
Circulation. Arrhythmia and electrophysiology 2011;4(4):592-3.
2011: M Kranzfelder; T Schuster; Hans Geinitz; Helmut Friess; Peter Büchler
Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
The British journal of surgery 2011;98(6):768-83.
2011: Martin Loos; Irene Esposito; Dennis M Hedderich; Leopold Ludwig; Alexander Fingerle; Helmut Friess; Günter Klöppel; Peter Büchler
Autoimmune pancreatitis complicated by carcinoma of the pancreatobiliary system: a case report and review of the literature.
Pancreas 2011;40(1):151-4.
2010: Leopold Ludwig; Peter Büchler; Jörg Kleeff; Jochen Gaa; Manfred Stangl; Christian Prinz; Rupert Langer; Helmut Friess; Roland M Schmid; Hana Algül
Multidisciplinary treatment of aggressive and rapidly progressing biliary papillomatosis.
Digestive diseases and sciences 2010;55(12):3627-9.
2010: Michael Kranzfelder; Peter Büchler; Konstanze Lange; Helmut Friess
Treatment options for squamous cell cancer of the esophagus: a systematic review of the literature.
Journal of the American College of Surgeons 2010;210(3):351-9.
2009: Peter Büchler; Howard A Reber; James Tomlinson; Oliver Hankinson; Georgios Kallifatidis; Helmut Friess; Ingrid Herr; Oscar J Hines
Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.
Neoplasia (New York, N.Y.) 2009;11(2):196-206.
2009: M Kranzfelder; Peter Büchler; Helmut Friess
Surgery within multimodal therapy concepts for esophageal squamous cell carcinoma (ESCC): the MRI approach and review of the literature.
Advances in medical sciences 2009;54(2):158-69.
2009: Andre Mihaljevic; Peter Büchler; Jan Harder; Ralf Hofheinz; Michael Gregor; Stephan Kanzler; Wolff Schmiegel; Volker Heinemann; Esther Endlicher; Günter Klöppel; Thomas Seufferlein; Michael Geissler
A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer.
BMC surgery 2009;9():1.
2009: Michael W Müller; Volker Assfalg; C W Michalski; Peter Büchler; Jörg Kleeff; Helmut Friess
[Middle segmental pancreatic resection: an organ-preserving option for benign lesions].
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2009;80(1):14-21.
2007: Michael W Müller; Nathalia A Giese; Jakub M Swiercz; Güralp O Ceyhan; Irene Esposito; Ulf Hinz; Peter Büchler; Thomas Giese; Markus W Büchler; Stefan Offermanns; Helmut Friess
Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
International journal of cancer. Journal international du cancer 2007;121(11):2421-33.
2007: Michael W Müller; Paul L McNeil; Peter Büchler; Güralp O Ceyhan; Elke Wolf-Hieber; Guido Adler; Hans G Beger; Markus W Büchler; Helmut Friess
Acinar cell membrane disruption is an early event in experimental acute pancreatitis in rats.
Pancreas 2007;35(4):e30-40.
2007: Jamael El Fitori; Yun Su; Peter Büchler; Roman Ludwig; Nathalia A Giese; Markus W Büchler; Hilmar Quentmeier; Oscar J Hines; Ingrid Herr; Helmut Friess
PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer.
Cancer 2007;110(7):1457-68.
2007: Peter Büchler; Howard A Reber; Mendel M Roth; Mark Shiroishi; Helmut Friess; Oscar J Hines
Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.
Neoplasia (New York, N.Y.) 2007;9(2):119-27.
2007: Chengwen Zhang; Till Wenger; Jürgen Mattern; Septimia Ilea; Christian R Frey; Paul Gutwein; Peter Altevogt; Wolfram Bodenmüller; Nikolaus Gassler; Philipp A Schnabel; Hendrik Dienemann; Alexander Marmé; Markus Hohenfellner; Axel Haferkamp; Jesco Pfitzenmaier; Hermann-Josef Gröne; Armin Kolb; Peter Büchler; Markus Büchler; Helmut Friess; Werner Rittgen; Lutz Edler; Klaus-Michael Debatin; Peter H Krammer; Hans Peter Rutz; Ingrid Herr
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors.
Cancer biology & therapy 2007;6(2):278-87.
2006: Yun Su; Peter Büchler; Amiq Gazdhar; Nathalia A Giese; Howard A Reber; Oscar J Hines; Thomas Giese; Markus W Büchler; Helmut Friess
Pancreatic regeneration in chronic pancreatitis requires activation of the notch signaling pathway.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2006;10(9):1230-41; discussion 1242.
2006: Chengwen Zhang; Benjamin Beckermann; Georgios Kallifatidis; Zheng Liu; Werner Rittgen; Lutz Edler; Peter Büchler; Klaus-Michael Debatin; Markus W Büchler; Helmut Friess; Ingrid Herr
Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.
International journal of oncology 2006;29(5):1295-301.
2006: Thilo Welsch; Jörg Kleeff; Helmut K Seitz; Peter Büchler; Helmut Friess; Markus W Büchler
Update on pancreatic cancer and alcohol-associated risk.
Journal of gastroenterology and hepatology 2006;21 Suppl 3():S69-75.
2006: Peter Büchler; David Martin; Markus W Büchler
[Management qualifications for academic surgeons in the future: what can we learn from business administration?].
Cirugía española 2006;79(5):274-82.
2006: Tom M Ganten; Ronald Koschny; Jaromir Sykora; Henning Schulze-Bergkamen; Peter Büchler; Tobias L Haas; Manuela B Schader; Andreas Untergasser; Wolfgang Stremmel; Henning Walczak
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2640-6.
2006: Peter Büchler; David Martin; Hanns-Peter Knaebel; Markus W Büchler
Leadership characteristics and business management in modern academic surgery.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2006;391(2):149-56.
2006: Martin Schneider; Peter Büchler; Nathalia A Giese; Thomas Giese; Jörg Wilting; Markus W Büchler; Helmut Friess
Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
International journal of oncology 2006;28(4):883-90.
2006: Shailesh Shrikhande; Peter Büchler; Irene Esposito; Martin Loos; Markus W Büchler; Helmut Friess
Splenic and portal vein thrombosis in pancreatic metastasis from renal cell carcinoma.
World journal of surgical oncology 2006;4():25.
2006: Chengwen Zhang; Armin Kolb; Peter Büchler; Andrew C B Cato; Jürgen Mattern; Werner Rittgen; Lutz Edler; Klaus-Michael Debatin; Markus W Büchler; Helmut Friess; Ingrid Herr
Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.
BMC cancer 2006;6():61.
2005: Peter Büchler; Amiq Gazdhar; Mario Schubert; Nathalia A Giese; Howard A Reber; Oscar J Hines; Thomas Giese; Güralp O Ceyhan; Michael Müller; Markus W Büchler; Helmut Friess
The Notch signaling pathway is related to neurovascular progression of pancreatic cancer.
Annals of surgery 2005;242(6):791-800, discussion 800-1.
2005: Peter Büchler; Howard A Reber; Guido Eibl; Mendel A Roth; Markus W Büchler; Helmut Friess; William H Isacoff; Oscar J Hines
Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy.
International journal of oncology 2005;27(4):1125-30.
2004: Peter Büchler; Howard A Reber; Robert S Lavey; James Tomlinson; Markus W Büchler; Helmut Friess; Oscar J Hines
Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model.
The Journal of surgical research 2004;120(2):295-303.
2004: Henning Schulze-Bergkamen; Dirk Brenner; Andreas Krueger; Dorothee Suess; Stefanie C Fas; Christian R Frey; Andreas Dax; Dorothea Zink; Peter Büchler; Martina Müller; Peter H Krammer
Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt.
Hepatology (Baltimore, Md.) 2004;39(3):645-54.
2004: Peter Büchler; Howard A Reber; Markus W Büchler; Helmut Friess; Robert S Lavey; Oscar J Hines
Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression.
Cancer 2004;100(1):201-10.
2003: Peter Büchler; Howard A Reber; Axel Ullrich; Mark Shiroiki; Mendel Roth; Markus W Büchler; Robert S Lavey; Helmut Friess; Oscar J Hines
Pancreatic cancer growth is inhibited by blockade of VEGF-RII.
Surgery 2003;134(5):772-82.
2003: Peter Büchler; Thomas W Kraus; Helmut Friess; Markus W Büchler
Labor legislation in the European Union has impact on workforce management in surgical centers.
Surgery 2003;134(1):3-11.
2003: Dale E Bockman; Junchao Guo; Peter Büchler; Michael W Müller; Frank Bergmann; Helmut Friess
Origin and development of the precursor lesions in experimental pancreatic cancer in rats.
Laboratory investigation; a journal of technical methods and pathology 2003;83(6):853-9.
2003: Henning Schulze-Bergkamen; Andreas Untergasser; Andreas Dax; Heiko Vogel; Peter Büchler; Ernst Klar; Thomas Lehnert; Helmut Friess; Markus W Büchler; Michael Kirschfink; Wolfgang Stremmel; Peter H Krammer; Martina Müller; Ulrike Protzer
Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection.
Journal of hepatology 2003;38(6):736-44.
2003: Peter Büchler; Anna S Gukovskaya; Michelle Mouria; Manuela C Büchler; Markus W Büchler; Helmut Friess; Stephen J Pandol; Howard A Reber; Oscar J Hines
Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid.
Pancreas 2003;26(3):264-73.
2003: Shereen Keleg; Peter Büchler; Roman Ludwig; Markus W Büchler; Helmut Friess
Invasion and metastasis in pancreatic cancer.
Molecular cancer 2003;2():14.
2003: Peter Büchler; Howard A Reber; Manuela Büchler; Shailesh Shrinkante; Markus W Büchler; Helmut Friess; Gregg L Semenza; Oscar J Hines
Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.
Pancreas 2003;26(1):56-64.
2002: Peter Büchler; Howard A Reber; Markus W Büchler; Helmut Friess; Oscar J Hines
VEGF-RII influences the prognosis of pancreatic cancer.
Annals of surgery 2002;236(6):738-49; discussion 749.
2002: Peter Büchler; joachim pfannschmidt; B Rudek; Hendrik Dienemann; Thomas Lehnert
Surgical treatment of hepatic and pulmonary metastases from non-colorectal and non-neuroendocrine carcinoma.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2002;91(2):147-54.
2002: Moritz Wente; Peter Büchler; Helmut Friess; Markus W Büchler
Adjuvant therapy in operable pancreatic cancer.
Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera 2002;8(2):74-80.
2002: Fabio F di Mola; Helmut Friess; Erick Riesle; Alexander Koliopanos; Peter Büchler; Zhaowen Zhu; David R Brigstock; Murray Korc; Markus W Büchler
Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.
Annals of surgery 2002;235(1):60-7.
2001: Peter Büchler; Howard A Reber; M C Büchler; M A Roth; Markus W Büchler; Helmut Friess; William H Isacoff; Oscar J Hines
Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin).
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2001;5(2):139-46.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.